Affymetrix, Inc., AFFX today announced that based on preliminary
financial data, the Company expects total revenue for the fourth quarter of
2012 will be approximately $84 million, including $18 million from its
eBioscience business unit. Excluding eBioscience, the Company's revenue
increased by 1% as compared to the fourth quarter of 2011, and eBioscience's
revenue increased by approximately 5% as compared to the fourth quarter of
2011. For fiscal 2012, the Company expects total revenue of approximately $295
million.
The company also announced that it prepaid $9.6 million of its senior-secured
debt and is implementing a corporate restructuring to accelerate the Company's
path to profitability. The restructuring is expected to result in annualized
savings of approximately $25 million based on 2013 run rates, of which $5
million is in cost-of-goods sold. As part of the restructuring, Affymetrix
expects that more than 100 employees will leave the company, representing
about 8% of its work force. The company expects to record a charge of
approximately $7 million, the majority of which will be incurred during the
first quarter of 2013.
“This restructuring will drive operational efficiency, and together with the
sharpened focus of our development and commercial priorities, will accelerate
our return to profitability,” said Dr. Frank Witney, president and chief
executive officer.
In conjunction with this announcement, the Company's EVP and general counsel
John F. (Rick) Runkel will retire from Affymetrix effective March 31, 2013.
Mr. Runkel will be succeeded by Ms. Siang Chin. Ms. Chin joined the company in
2007 as vice president, chief corporate counsel.
Affymetrix's management team will host a conference call on Thursday January
31, 2013 at 2:00 p.m. PT. A live webcast can be accessed by visiting the
Investor Relations section of the Company's website at www.affymetrix.com. In
addition, investors and other interested parties can listen by dialing
domestic: (877) 407-4812, international: (201) 689-8345.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in